ProKidney Corp. reported Friday a $61.2 million loss in fiscal 2024 as the biotechnology company resumed production and retrenched its growth plans to its Winston-Salem facilities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback